A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
Deplanque, G., Demarchi, M., Hebbar, M., Flynn, P., Melichar, B., Atkins, J., Nowara, E., Moyé, L., Piquemal, D., Ritter, D., Dubreuil, P., Mansfield, C.D., Acin, Y., Moussy, A., Hermine, O., Hammel, P.
Published in Annals of oncology (01.06.2015)
Published in Annals of oncology (01.06.2015)
Get full text
Journal Article
A homozygous nonsense variant in IFT52 is associated with a human skeletal ciliopathy
Girisha, K. M., Shukla, A., Trujillano, D., Bhavani, G. S., Hebbar, M., Kadavigere, R., Rolfs, A.
Published in Clinical genetics (01.12.2016)
Published in Clinical genetics (01.12.2016)
Get full text
Journal Article
Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV
Lévi, F.A., Boige, V., Hebbar, M., Smith, D., Lepère, C., Focan, C., Karaboué, A., Guimbaud, R., Carvalho, C., Tumolo, S., Innominato, P., Ajavon, Y., Truant, S., Castaing, D., De Baere, T., Kunstlinger, F., Bouchahda, M., Afshar, M., Rougier, P., Adam, R., Ducreux, M.
Published in Annals of oncology (01.02.2016)
Published in Annals of oncology (01.02.2016)
Get full text
Journal Article
Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child‐Pugh score
Hollebecque, A., Cattan, S., Romano, O., Sergent, G., Mourad, A., Louvet, A., Dharancy, S., Boleslawski, E., Truant, S., Pruvot, F.‐R., Hebbar, M., Ernst, O., Mathurin, P.
Published in Alimentary Pharmacology & Therapeutics (Suppl) (01.11.2011)
Published in Alimentary Pharmacology & Therapeutics (Suppl) (01.11.2011)
Get full text
Journal Article
Laparoscopic resection vs. open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a case-matched study
Truant, S., Bouras, A. F., Hebbar, M., Boleslawski, E., Fromont, G., Dharancy, S., Leteurtre, E., Zerbib, P., Pruvot, F. R.
Published in Surgical endoscopy (01.11.2011)
Published in Surgical endoscopy (01.11.2011)
Get full text
Journal Article
Tumor size of hepatocellular carcinoma in noncirrhotic liver: A controversial predictive factor for outcome after resection
Truant, S, Boleslawski, E, Duhamel, A, Bouras, A.-F, Louvet, A, Febvay, C, Leteurtre, E, Huet, G, Zerbib, P, Dharancy, S, Hebbar, M, Pruvot, F.-R
Published in European journal of surgical oncology (01.12.2012)
Published in European journal of surgical oncology (01.12.2012)
Get full text
Journal Article
Safety and efficacy of folfirinox in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis
Baldini, C, Escande, A, Bouché, O, El Hajbi, F, Volet, J, Bourgeois, V, Renaut Vantroys, T, Ploquin, A, Desauw, C, Hebbar, M
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01.01.2017)
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01.01.2017)
Get full text
Journal Article
1326 Folfirinage: Tolerance and efficacy of folfirinox in elderly patients with advanced pancreatic adenocarcinoma
Baldini, C, Escande, A, Bouché, O, Bourgeois, V, Renaut-Vantroys, T, Ploquin, A, Desauw, C, Hebbar, M
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
2294 Growth modulation index (GMI) to assess salvage chemotherapy benefit after FOLFIRINOX progression in metastatic pancreatic adenocarcinoma
Ducoulombier, A, Quintin, J, Desjardin, M, Hautefeuille, V, Desauw, C, Parzy, A, Bouche, O, Chauffert, B, Clisant, S, El Hajbi, F, Becouarn, Y, Bennouna, J, Hebbar, M, Penel, N, Adenis, A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial
Hebbar, M., Chibaudel, B., André, T., Mineur, L., Smith, D., Louvet, C., Dutel, J.L., Ychou, M., Legoux, J.L., Mabro, M., Faroux, R., Auby, D., Brusquant, D., Khalil, A., Truant, S., Hadengue, A., Dalban, C., Gayet, B., Paye, F., Pruvot, F.R., Bonnetain, F., Taieb, J., Brucker, P., Landi, B., Flesch, M., Carola, E., Martin, P., Vaillant, E., de Gramont, A.
Published in Annals of oncology (01.02.2015)
Published in Annals of oncology (01.02.2015)
Get full text
Journal Article
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer
CONROY, T, HEBBAR, M, DOUILLARD, J. Y, BENNOUNA, J, DUCREUX, M, YCHOU, M, LLEDO, G, ADENIS, A, FAROUX, R, REBISCHUNG, C, KOCKLER, L
Published in British journal of cancer (05.01.2010)
Published in British journal of cancer (05.01.2010)
Get full text
Journal Article
2305 Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part
Hebbar, M, Heurgue-Berlot, A, Boige, V, Le Malicot, K, Bernard-Chabert, B, Marcus, C, Dharancy, S, Sergent, G, Perarnau, J.M, Ehrhard, F, Ollivier-Hourmand, I, Vergniol, J, Michel, P, Edeline, J, Rinaldi, Y, Seitz, J.F, Lepage, C, De Baere, T
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial
Hebbar, M., Chibaudel, B., André, T., Mineur, L., Smith, D., Louvet, C., Dutel, J.L., Ychou, M., Legoux, J.L., Mabro, M., Faroux, R., Auby, D., Brusquant, D., Khalil, A., Truant, S., Hadengue, A., Dalban, C., Gayet, B., Paye, F., Pruvot, F.R., Bonnetain, F., de Gramont, A.
Published in Annals of oncology (01.05.2015)
Published in Annals of oncology (01.05.2015)
Get full text
Journal Article
Prognostic Value of the Type I Growth Factor Receptors in a Large Series of Human Primary Breast Cancers Quantified with a Real-Time Reverse Transcription-Polymerase Chain Reaction Assay
PAWLOWSKI, Valérie, REVILLION, Francoise, HEBBAR, Mohamed, HORNEZ, Louis, PEYRAT, Jean-Philippe
Published in Clinical cancer research (01.11.2000)
Get full text
Published in Clinical cancer research (01.11.2000)
Journal Article
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study
André, T., Tournigand, C., Mineur, L., Fellague-Chebra, R., Flesch, M., Mabro, M., Hebbar, M., Postel Vinay, S., Bidard, F.C., Louvet, C., de Gramont, A.
Published in Annals of oncology (01.01.2007)
Published in Annals of oncology (01.01.2007)
Get full text
Journal Article
Cost-Minimisation Analysis in First-Line Treatment of Metastatic Colorectal Cancer in France: XELOX versus FOLFOX-6
Perrocheau, G., Bennouna, J., Ducreux, M., Hebbar, M., Ychou, M., Lledo, G., Conroy, T., Dominguez, S., Faroux, R., Florentin, V., Douillard, J.Y.
Published in Oncology (01.01.2010)
Published in Oncology (01.01.2010)
Get full text
Journal Article